Flatt Jumps to Synthetic Genomics
Bruce V. Bigelow5/14/10
San Diego’s Synthetic Genomics, which said last year it’s getting at least $300 million from ExxonMobil to develop algae-based biofuels, has named James Flatt as its new chief technology officer, effective May 19. Flatt previously served as the senior vice president of research at Mascoma Biosciences, a cellulosic ethanol developer that moved last fall from Boston to Lebanon, NH.
